HCPCS Service Codes - Medical care

HCPCS Service Code 1 for Medical care.

HCPCS Type of Service (TOS) code is an indicator that the contractor places on Form CMS-1500. The indicator is mainly used for data purposes, however in some instances, it affects payment. All HCPCS codes have a corresponding TOS indicator.

Below are all available HCPCS TOS codes. Find an HCPCS code based on the type of service.

HCPCS Codes for Medical care

  • J3240

    Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial

  • J3241

    Injection, teprotumumab-trbw, 10 mg

  • J3243

    Injection, tigecycline, 1 mg

  • J3244

    Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg

  • J3245

    Injection, tildrakizumab, 1 mg

  • J3246

    Injection, tirofiban hcl, 0.25 mg

  • J3247

    Injection, secukinumab, intravenous, 1 mg

  • J3250

    Injection, trimethobenzamide hcl, up to 200 mg

  • J3260

    Injection, tobramycin sulfate, up to 80 mg

  • J3262

    Injection, tocilizumab, 1 mg

  • J3263

    Injection, toripalimab-tpzi, 1 mg

  • J3265

    Injection, torsemide, 10 mg/ml

  • J3280

    Injection, thiethylperazine maleate, up to 10 mg

  • J3285

    Injection, treprostinil, 1 mg

  • J3290

    Injection, tranexamic acid, 5 mg

  • J3291

    Injection, tranexamic acid in sodium chloride, 5 mg

  • J3299

    Injection, triamcinolone acetonide (xipere), 1 mg

  • J3300

    Injection, triamcinolone acetonide, preservative free, 1 mg

  • J3301

    Injection, triamcinolone acetonide, not otherwise specified, 10 mg

  • J3302

    Injection, triamcinolone diacetate, per 5 mg

  • J3303

    Injection, triamcinolone hexacetonide, per 5 mg

  • J3304

    Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

  • J3305

    Injection, trimetrexate glucuronate, per 25 mg

  • J3310

    Injection, perphenazine, up to 5 mg

  • J3315

    Injection, triptorelin pamoate, 3.75 mg

  • J3316

    Injection, triptorelin, extended-release, 3.75 mg

  • J3320

    Injection, spectinomycin dihydrochloride, up to 2 gm

  • J3350

    Injection, urea, up to 40 gm

  • J3355

    Injection, urofollitropin, 75 iu

  • J3357

    Ustekinumab, for subcutaneous injection, 1 mg

  • J3358

    Ustekinumab, for intravenous injection, 1 mg

  • J3360

    Injection, diazepam, up to 5 mg

  • J3364

    Injection, urokinase, 5000 iu vial

  • J3365

    Injection, iv, urokinase, 250,000 i.u. vial

  • J3370

    Injection, vancomycin hcl, 500 mg

  • J3371

    Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg

  • J3372

    Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg

  • J3373

    Injection, vancomycin hydrochloride, 10 mg

  • J3374

    Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg

  • J3375

    Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg

  • J3376

    Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg

  • J3379

    Injection, valproate sodium, 5 mg

  • J3380

    Injection, vedolizumab, intravenous, 1 mg

  • J3385

    Injection, velaglucerase alfa, 100 units

  • J3387

    Injection, elivaldogene autotemcel, per treatment

  • J3389

    Topical administration, prademagene zamikeracel, per treatment

  • J3391

    Injection, atidarsagene autotemcel, per treatment

  • J3392

    Injection, exagamglogene autotemcel, per treatment

  • J3393

    Injection, betibeglogene autotemcel, per treatment

  • J3394

    Injection, lovotibeglogene autotemcel, per treatment